Edgewise Therapeutics, Inc. (EWTX)
NASDAQ: EWTX · Real-Time Price · USD
28.18
+0.36 (1.29%)
Mar 9, 2026, 1:18 PM EDT - Market open
Edgewise Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Selling, General & Admin | 40.02 | 31.87 | 23.45 | 17.63 | 11.03 | |
| Research & Development | 151.39 | 126.97 | 90.91 | 54.03 | 32.19 | |
| Operating Expenses | 191.41 | 158.83 | 114.36 | 71.66 | 43.22 | |
| Operating Income | -191.41 | -158.83 | -114.36 | -71.66 | -43.22 | |
| Interest & Investment Income | 23.61 | 25.02 | 14.19 | 4.02 | 0.4 | |
| Pretax Income | -167.8 | -133.81 | -100.16 | -67.64 | -42.81 | |
| Net Income | -167.8 | -133.81 | -100.16 | -67.64 | -42.81 | |
| Net Income to Common | -167.8 | -133.81 | -100.16 | -67.64 | -42.81 | |
| Shares Outstanding (Basic) | 103 | 92 | 64 | 54 | 38 | |
| Shares Outstanding (Diluted) | 103 | 92 | 64 | 54 | 38 | |
| Shares Change (YoY) | 11.38% | 45.02% | 18.90% | 42.82% | 4977.96% | |
| EPS (Basic) | -1.63 | -1.45 | -1.57 | -1.26 | -1.14 | |
| EPS (Diluted) | -1.63 | -1.45 | -1.57 | -1.26 | -1.14 | |
| Free Cash Flow | -144.07 | -110.34 | -97.69 | -58.18 | -34.18 | |
| Free Cash Flow Per Share | -1.40 | -1.19 | -1.53 | -1.09 | -0.91 | |
| EBITDA | -189.32 | -156.76 | -112.81 | -71.29 | -42.94 | |
| D&A For EBITDA | 2.08 | 2.07 | 1.55 | 0.37 | 0.27 | |
| EBIT | -191.41 | -158.83 | -114.36 | -71.66 | -43.22 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.